Vanguard Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Vanguard Capital Management's RPRX Position: Q3 2026 in Review
Vanguard Capital Management increased its Royalty Pharma (RPRX) stake by 12% in Q3 2026, buying an estimated $33.9M and bringing the position to 5,401,661 shares worth $315M. The position accounts for 0.01% of the portfolio, ranked #856.
Vanguard Capital Management first reported a position in RPRX in Q1 2026 and has held it in 3 quarters since. 703 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Vanguard Capital Management held 5,401,661 shares of Royalty Pharma worth $315M as of Q3 2026.
- Vanguard Capital Management bought 575,044 Royalty Pharma shares in Q3 2026, an estimated $33.9M.
- Royalty Pharma made up 0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #856 holding.
- Vanguard Capital Management first reported a position in Royalty Pharma in Q1 2026 and has held it in 3 quarters since.
- 703 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.